---
title: "Medartis Holding AG announces upcoming annual results presentation and outlook conference"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/275429724.md"
datetime: "2026-02-10T09:00:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275429724.md)
  - [en](https://longbridge.com/en/news/275429724.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275429724.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/275429724.md) | [繁體中文](https://longbridge.com/zh-HK/news/275429724.md)


# Medartis Holding AG announces upcoming annual results presentation and outlook conference

Medartis Holding AG will present its 2025 full year results and 2026 outlook on Tuesday, 17 March 2026 in Basel. Results documents, including the press release, integrated annual report, and conference presentation, will be published on the Medartis corporate website) before 07:00 am. A press and investor conference will be held from 10:30 to 11:30 (Swiss time) at Medartis HQ in Basel, with a simultaneous online webcast). The event will be attended by CEO Matthias Schupp and CFO Peter Hackel. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medartis Holding AG published the original content used to generate this news brief via EQS News, a service of EQS Group AG (Ref. ID: corporate\_2274032\_en), on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

## 相关资讯与研究

- [Omeros Turns Corner With Novo Deal, YARTEMLEA Launch](https://longbridge.com/zh-CN/news/281666535.md)
- [<![CDATA[Expanding Access to Whole-Genome Testing for Children: Q&A with Drs. Ryan Taft and Stacy Musone]]>](https://longbridge.com/zh-CN/news/281626394.md)
- [Top NeurAxis Insiders Make Bold Moves With Fresh Stock Buys](https://longbridge.com/zh-CN/news/281670217.md)
- [RBC Capital Reaffirms Their Buy Rating on Insulet (PODD)](https://longbridge.com/zh-CN/news/281669086.md)
- [OMER S.p.A.: Resilient Fundamentals and Structural Growth Support Buy Rating Despite Softer FY26 Outlook](https://longbridge.com/zh-CN/news/281649119.md)